BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27672697)

  • 21. Glycation of type I collagen selectively targets the same helical domain lysine sites as lysyl oxidase-mediated cross-linking.
    Hudson DM; Archer M; King KB; Eyre DR
    J Biol Chem; 2018 Oct; 293(40):15620-15627. PubMed ID: 30143533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glyoxal-derived advanced glycation end-products, N
    Kang J; Jeong YJ; Ha SK; Lee HH; Lee KW
    Mol Biol Rep; 2023 Mar; 50(3):2511-2520. PubMed ID: 36609749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of AGE-precursors and AGE formation in glycation-induced BSA peptides.
    Ahmad W; Li L; Deng Y
    BMB Rep; 2008 Jul; 41(7):516-22. PubMed ID: 18682035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid-phase synthesis of D-fructose-derived Heyns peptides utilizing N
    Schmutzler S; Knappe D; Marx A; Hoffmann R
    Amino Acids; 2021 Jun; 53(6):881-891. PubMed ID: 33934222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel α-Oxoamide Advanced-Glycation Endproducts within the N
    Baldensperger T; Jost T; Zipprich A; Glomb MA
    J Agric Food Chem; 2018 Feb; 66(8):1898-1906. PubMed ID: 29436827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific synthesis of Amadori-modified peptides on solid phase.
    Frolov A; Singer D; Hoffmann R
    J Pept Sci; 2006 Jun; 12(6):389-95. PubMed ID: 16342332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of a synthetic glucose derived advanced glycation end product that is immunologically cross-reactive with its naturally occurring counterparts.
    Al-Abed Y; Bucala R
    Bioconjug Chem; 2000; 11(1):39-45. PubMed ID: 10639083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective.
    Thornalley PJ; Rabbani N
    Biochim Biophys Acta; 2014 Feb; 1840(2):818-29. PubMed ID: 23558060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo.
    Takeuchi M; Makita Z
    Curr Mol Med; 2001 Jul; 1(3):305-15. PubMed ID: 11899079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tandem mass spectrometry for the study of glyoxal-derived advanced glycation end-products (AGEs) in peptides.
    Lopez-Clavijo AF; Duque-Daza CA; O'Connor PB
    Rapid Commun Mass Spectrom; 2014 Jan; 28(1):25-32. PubMed ID: 24285387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster.
    Tsakiri EN; Iliaki KK; Höhn A; Grimm S; Papassideri IS; Grune T; Trougakos IP
    Free Radic Biol Med; 2013 Dec; 65():1155-1163. PubMed ID: 23999505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Free and Protein-Bound Maillard Reaction Products N-ε-Carboxymethyllysine, N-ε-Fructosyllysine, and Pyrraline on Nrf2 and NFκB in HCT 116 Cells.
    Raupbach J; Müller SK; Schnell V; Friedrich S; Hellwig A; Grune T; Henle T
    Mol Nutr Food Res; 2023 Sep; 67(18):e2300137. PubMed ID: 37465844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.
    Ahmed MU; Brinkmann Frye E; Degenhardt TP; Thorpe SR; Baynes JW
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):565-70. PubMed ID: 9182719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of advanced glycation end product-associated protein cross-linking.
    Lehman TD; Ortwerth BJ
    Biochim Biophys Acta; 2001 Feb; 1535(2):110-9. PubMed ID: 11341999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of advanced glycation endproducts during fish sausage preparation by transglutaminase and chitosan oligosaccharides induced enzymatic glycosylation.
    Wang J; Zou L; Yuan F; Lv L; Tian S; Li Z; Lin H
    Food Funct; 2018 Jan; 9(1):253-262. PubMed ID: 29168862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of N epsilon-(carboxyethyl)lysine, one of the methylglyoxal-derived AGE structures, in glucose-modified protein: mechanism for protein modification by reactive aldehydes.
    Nagai R; Araki T; Hayashi CM; Hayase F; Horiuchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):75-84. PubMed ID: 12668073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins.
    Nagaraj RH; Monnier VM
    Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances.
    Ajith TA; Vinodkumar P
    Curr Clin Pharmacol; 2016; 11(2):118-27. PubMed ID: 27164965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Wa C; Cerny RL; Clarke WA; Hage DS
    Clin Chim Acta; 2007 Oct; 385(1-2):48-60. PubMed ID: 17707360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of Peptide Bound Pyrraline in the Maillard Model Systems with Different Lys-Containing Dipeptides and Tripeptides.
    Liang Z; Li L; Qi H; Wan L; Cai P; Xu Z; Li B
    Molecules; 2016 Apr; 21(4):463. PubMed ID: 27070556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.